Garyfallia Papaioannou, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chondrocytes | 7 | 2017 | 799 | 1.290 |
Why?
|
Hypoparathyroidism | 1 | 2024 | 136 | 0.810 |
Why?
|
Osteogenesis | 2 | 2016 | 1282 | 0.610 |
Why?
|
Proto-Oncogene Proteins A-raf | 1 | 2017 | 9 | 0.560 |
Why?
|
MicroRNAs | 6 | 2018 | 3785 | 0.550 |
Why?
|
Growth Plate | 3 | 2017 | 273 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 206 | 0.520 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 474 | 0.490 |
Why?
|
Chondrogenesis | 1 | 2017 | 238 | 0.480 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 479 | 0.480 |
Why?
|
Bone Development | 2 | 2017 | 468 | 0.450 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2015 | 327 | 0.440 |
Why?
|
Histone Deacetylases | 1 | 2015 | 708 | 0.350 |
Why?
|
Mitogens | 1 | 2010 | 228 | 0.350 |
Why?
|
Osteoblasts | 1 | 2014 | 1143 | 0.310 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1761 | 0.300 |
Why?
|
Thyroid Diseases | 2 | 2010 | 388 | 0.290 |
Why?
|
Cyclosporine | 1 | 2010 | 778 | 0.290 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2054 | 0.270 |
Why?
|
Signal Transduction | 4 | 2018 | 23601 | 0.240 |
Why?
|
Stem Cells | 2 | 2016 | 3540 | 0.230 |
Why?
|
Diphosphonates | 3 | 2014 | 625 | 0.220 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3607 | 0.210 |
Why?
|
Imidazoles | 3 | 2014 | 1162 | 0.200 |
Why?
|
Lymphocytes | 1 | 2010 | 2599 | 0.200 |
Why?
|
Calcitriol | 1 | 2024 | 299 | 0.200 |
Why?
|
Hypocalcemia | 1 | 2024 | 205 | 0.200 |
Why?
|
Helicobacter pylori | 2 | 2019 | 380 | 0.190 |
Why?
|
Helicobacter Infections | 2 | 2019 | 390 | 0.190 |
Why?
|
Bone Density Conservation Agents | 3 | 2014 | 791 | 0.190 |
Why?
|
Osteoporosis, Postmenopausal | 3 | 2014 | 399 | 0.180 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5501 | 0.160 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4209 | 0.140 |
Why?
|
Cartilage, Articular | 2 | 2015 | 1089 | 0.140 |
Why?
|
Limb Deformities, Congenital | 1 | 2018 | 136 | 0.140 |
Why?
|
Osteoarthritis | 2 | 2015 | 1051 | 0.140 |
Why?
|
Tracheoesophageal Fistula | 1 | 2018 | 129 | 0.130 |
Why?
|
raf Kinases | 1 | 2017 | 116 | 0.130 |
Why?
|
Collagen Type II | 1 | 2016 | 151 | 0.130 |
Why?
|
Eyelids | 1 | 2018 | 279 | 0.120 |
Why?
|
Microcephaly | 1 | 2018 | 426 | 0.110 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 361 | 0.110 |
Why?
|
Hypertrophy | 1 | 2015 | 559 | 0.110 |
Why?
|
Phosphates | 1 | 2017 | 763 | 0.100 |
Why?
|
HMGA2 Protein | 1 | 2013 | 101 | 0.100 |
Why?
|
Ribonuclease III | 1 | 2015 | 269 | 0.100 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2013 | 101 | 0.100 |
Why?
|
Cell Proliferation | 4 | 2016 | 10429 | 0.100 |
Why?
|
Cell Count | 1 | 2016 | 1823 | 0.100 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 618 | 0.100 |
Why?
|
Calcium | 2 | 2024 | 5767 | 0.100 |
Why?
|
Wnt Proteins | 1 | 2016 | 722 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1718 | 0.100 |
Why?
|
Cell Death | 2 | 2015 | 1679 | 0.090 |
Why?
|
Osteoporosis | 2 | 2019 | 1582 | 0.090 |
Why?
|
Organ Size | 1 | 2016 | 2260 | 0.090 |
Why?
|
Stromal Cells | 1 | 2016 | 1329 | 0.090 |
Why?
|
Bone Diseases | 1 | 2014 | 411 | 0.090 |
Why?
|
Oncogenes | 1 | 2016 | 1235 | 0.090 |
Why?
|
Cell Lineage | 2 | 2016 | 2573 | 0.090 |
Why?
|
Carcinoma, Papillary | 2 | 2013 | 788 | 0.090 |
Why?
|
Mice, Knockout | 5 | 2018 | 14448 | 0.090 |
Why?
|
Carcinoma, Medullary | 1 | 2010 | 114 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1490 | 0.080 |
Why?
|
Thyrotropin | 2 | 2011 | 841 | 0.080 |
Why?
|
Animals | 9 | 2018 | 168764 | 0.080 |
Why?
|
Calcitonin | 1 | 2010 | 327 | 0.080 |
Why?
|
DNA Primers | 1 | 2013 | 2825 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1995 | 0.080 |
Why?
|
Thyroxine | 3 | 2011 | 672 | 0.080 |
Why?
|
RNA-Binding Proteins | 2 | 2015 | 1874 | 0.070 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9550 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2878 | 0.070 |
Why?
|
Endocrine System Diseases | 1 | 2009 | 243 | 0.070 |
Why?
|
Triiodothyronine | 2 | 2011 | 496 | 0.070 |
Why?
|
Mice | 5 | 2018 | 81819 | 0.070 |
Why?
|
Phosphorylation | 1 | 2017 | 8278 | 0.060 |
Why?
|
Bone and Bones | 1 | 2016 | 2554 | 0.060 |
Why?
|
Thyroid Nodule | 1 | 2013 | 779 | 0.060 |
Why?
|
Bone Remodeling | 1 | 2009 | 577 | 0.060 |
Why?
|
Wound Healing | 1 | 2016 | 2792 | 0.060 |
Why?
|
Thyroid Gland | 1 | 2011 | 1180 | 0.060 |
Why?
|
Thyroid Neoplasms | 3 | 2013 | 2371 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4137 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2017 | 18973 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3336 | 0.050 |
Why?
|
Thyroidectomy | 1 | 2009 | 916 | 0.050 |
Why?
|
Hypothyroidism | 2 | 2009 | 667 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.050 |
Why?
|
Base Sequence | 1 | 2013 | 12403 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 10729 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5772 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22332 | 0.050 |
Why?
|
Apoptosis | 1 | 2017 | 9514 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2010 | 3454 | 0.040 |
Why?
|
Female | 12 | 2024 | 396112 | 0.040 |
Why?
|
Hysterectomy | 1 | 2003 | 864 | 0.040 |
Why?
|
Gene Deletion | 2 | 2016 | 2666 | 0.040 |
Why?
|
Transcription Factors | 1 | 2016 | 12131 | 0.030 |
Why?
|
Granulation Tissue | 1 | 2016 | 92 | 0.030 |
Why?
|
Humans | 14 | 2024 | 765968 | 0.030 |
Why?
|
Interleukin-6 | 3 | 2014 | 3222 | 0.030 |
Why?
|
Adult | 3 | 2024 | 223044 | 0.030 |
Why?
|
Hydrocortisone | 2 | 2014 | 1827 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 637 | 0.030 |
Why?
|
Acute-Phase Reaction | 1 | 2014 | 90 | 0.030 |
Why?
|
Bone Diseases, Developmental | 1 | 2015 | 131 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 870 | 0.030 |
Why?
|
Kyphosis | 1 | 2016 | 251 | 0.030 |
Why?
|
Inflammation | 1 | 2013 | 10850 | 0.030 |
Why?
|
Resistin | 1 | 2014 | 174 | 0.030 |
Why?
|
Arthritis, Experimental | 1 | 2015 | 288 | 0.030 |
Why?
|
Greece | 1 | 2013 | 340 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1119 | 0.020 |
Why?
|
Triiodothyronine, Reverse | 1 | 2011 | 22 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4348 | 0.020 |
Why?
|
Heterozygote | 1 | 2018 | 2794 | 0.020 |
Why?
|
Middle Aged | 8 | 2014 | 223009 | 0.020 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3850 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2016 | 2669 | 0.020 |
Why?
|
Thyroid Function Tests | 1 | 2011 | 293 | 0.020 |
Why?
|
Tamoxifen | 1 | 2015 | 963 | 0.020 |
Why?
|
Adiponectin | 1 | 2014 | 1119 | 0.020 |
Why?
|
Phosphorus | 1 | 2009 | 337 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2016 | 11641 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2009 | 337 | 0.020 |
Why?
|
Male | 6 | 2018 | 363698 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2010 | 341 | 0.020 |
Why?
|
Leptin | 1 | 2014 | 1596 | 0.020 |
Why?
|
Collagen Type I | 1 | 2009 | 615 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3602 | 0.010 |
Why?
|
Comorbidity | 1 | 2019 | 10563 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 1009 | 0.010 |
Why?
|
Regression Analysis | 1 | 2013 | 6322 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2009 | 1789 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4893 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2887 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2009 | 869 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5876 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7421 | 0.010 |
Why?
|
Aged | 2 | 2010 | 171117 | 0.010 |
Why?
|
Thyroid Hormones | 1 | 2003 | 410 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11888 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3985 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12056 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6493 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10603 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18293 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 74840 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4331 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11206 | 0.010 |
Why?
|
Time Factors | 2 | 2009 | 40065 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13632 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2013 | 81514 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26318 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5891 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 65188 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29922 | 0.010 |
Why?
|
Prospective Studies | 1 | 2011 | 54802 | 0.000 |
Why?
|
Obesity | 1 | 2009 | 13076 | 0.000 |
Why?
|